Dokument Fact Sheet
Spezifizierung Immunthrombozytopenie (ITP) » rezidiviert/refraktär
Stand November 2020
Dies ist die aktuell gültige Version des Dokuments

1Romiplostim, ITP, relapsed/refractory

1 N - number of patients7 SAE - serious adverse events, CTCAE grade 3/412 OR - overall response13 TF - rate of treatment failure14 results for control, results for new therapy15 hazard ratio for new therapy19 platelets >50x109/L at any scheduled visit within 52 weeks20 platelets ≤20x109/L for 4 consecutive weeks